{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:30:08Z","timestamp":1781130608425,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening disorder characterized by systemic inflammation and organ failure as a result of dysregulated immune cell activation. HLH can be induced by a variety of factors including infection, tumours and autoimmune disease and can also occur in patients following solid organ transplantation. Occurrence of HLH and lupus nephritis (LN) successively within a short period of time after renal transplantation is uncommon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We described an 11-year-old female post-transplant patient who presented with hemocytopenia, fever, elevated serum ferritin, splenomegaly, hyperlipidemia, and hypofibrinemia, and was clinically diagnosed with HLH. After comprehensive treatment with corticosteroids, intravenous immunoglobulin (IVIG), and reducing immunosuppressants, her condition improved, but then hematuria ensued. The transplant kidney biopsy showed LN. She was treated with hydroxychloroquine and methylprednisolone while intensive immunosuppressive agents were given. She has remained in remission for two years until now.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The main inducing factors of HLH should be identified as early as possible, and accurate treatment plans should be taken. The long-course IVIG regimen may be one of the effective treatments for virus-induced HLH. After remission of HLH, we need to be alert to the recurrence of autoimmune diseases in patients with underlying diseases, and timely increase immunosuppressants.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03249-4","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:02:42Z","timestamp":1688374962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hemophagocytic lymphohistiocytosis secondary to virus infection and followed by lupus nephritis recurrence in a renal transplantation pediatric recipient: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longkai","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"6","key":"3249_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","volume":"30","author":"A Hayden","year":"2016","unstructured":"Hayden A, Park S, Giustini D, Lee AYY, Chen LYC. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411\u201320.","journal-title":"Blood Rev"},{"issue":"9","key":"3249_CR2","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1093\/ndt\/gfp282","volume":"24","author":"C Ponticelli","year":"2009","unstructured":"Ponticelli C, Alberighi ODC. Haemophagocytic syndrome\u2013a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24(9):2623\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3249_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.hoc.2015.06.009","volume":"29","author":"M Campo","year":"2015","unstructured":"Campo M, Berliner N. Hemophagocytic lymphohistiocytosis in adults. Hematol Oncol Clin North Am. 2015;29(5):915\u201325.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"3249_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s10875-021-01005-7","volume":"41","author":"BM Smits","year":"2021","unstructured":"Smits BM, van Montfrans J, Merrill SA, van de Corput L, van Gijn M, de Vries A, van den Bos C, Abbink F, van der Molen RG, Dors N, et al. A minimal parameter set facilitating early decision-making in the diagnosis of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2021;41(6):1219\u201328.","journal-title":"J Clin Immunol"},{"issue":"6","key":"3249_CR5","doi-asserted-by":"publisher","first-page":"e13732","DOI":"10.1111\/tid.13732","volume":"23","author":"E Vald\u00e9s Franc\u00ed","year":"2021","unstructured":"Vald\u00e9s Franc\u00ed E, Perez Flores I, Candel FJ, de la Moreno MA, Romero NC, Rodr\u00edguez Cubillo B, Lucena Valverde R, S\u00e1nchez Fructuoso AI. Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: case report and review of the literature. Transpl Infect Dis. 2021;23(6):e13732.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"3249_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"3249_CR7","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613\u201320.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3249_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12882-021-02538-0","volume":"22","author":"CJ Steffen","year":"2021","unstructured":"Steffen CJ, Koch N, Eckardt KU, Amann K, Seelow E, Schreiber A. Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report. BMC Nephrol. 2021;22(1):337.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3249_CR9","doi-asserted-by":"publisher","first-page":"e14134","DOI":"10.1111\/petr.14134","volume":"26","author":"NS Singh","year":"2022","unstructured":"Singh NS, Pagano AL, Hays AJ, Kats A, Dahl SM, Warady BA, Beins NT, Yin DE. Ehrlichia-induced hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient. Pediatr Transpl. 2022;26(1):e14134.","journal-title":"Pediatr Transpl"},{"issue":"1","key":"3249_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1590\/2175-8239-jbn-2018-0246","volume":"42","author":"J Naciso J\u00fanior","year":"2020","unstructured":"Naciso J\u00fanior J, Neri BdO, Dantas GLdA. Silveira LdHJ, sales MLdMBO, Freitas TVdS, Esmeraldo RdM: secondary hemophagocytic syndrome after renal transplantation: two case-reports. Jornal Brasileiro de Nefrologia. 2020;42(1):118\u201323.","journal-title":"Jornal Brasileiro de Nefrologia"},{"issue":"6","key":"3249_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/23744235.2021.1893379","volume":"53","author":"Y Bentata","year":"2021","unstructured":"Bentata Y. Parvovirus B19 in kidney transplantation: key points and essential pitfalls to know. Infect Dis (Lond). 2021;53(6):404\u20138.","journal-title":"Infect Dis (Lond)"},{"issue":"5","key":"3249_CR12","doi-asserted-by":"publisher","first-page":"ofz171","DOI":"10.1093\/ofid\/ofz171","volume":"6","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X, Zhang W, Cao Y, Luo H, Xu B, et al. Determination of Epstein-Barr Virus-Infected lymphocyte cell types in Peripheral Blood mononuclear cells as a Valuable Diagnostic Tool in Hematological Diseases. Open Forum Infect Dis. 2019;6(5):ofz171.","journal-title":"Open Forum Infect Dis"},{"key":"3249_CR13","doi-asserted-by":"publisher","first-page":"107606","DOI":"10.1016\/j.intimp.2021.107606","volume":"96","author":"G-Q Meng","year":"2021","unstructured":"Meng G-Q, Wang J-S, Wang Y-N, Wei N, Wang Z. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Int Immunopharmacol. 2021;96:107606.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"3249_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1681\/ASN.2009101093","volume":"21","author":"G Contreras","year":"2010","unstructured":"Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, et al. Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrology: JASN. 2010;21(7):1200\u20137.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"5","key":"3249_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.TP.0000053750.59630.83","volume":"75","author":"S Goral","year":"2003","unstructured":"Goral S, Ynares C, Shappell SB, Snyder S, Feurer ID, Kazancioglu R, Fogo AB, Helderman JH. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation. 2003;75(5):651\u20136.","journal-title":"Transplantation"},{"issue":"11","key":"3249_CR16","first-page":"1116","volume":"7","author":"G Nyberg","year":"1992","unstructured":"Nyberg G, Blohm\u00e9 I, Persson H, Olausson M, Svalander C. Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol Dial Transplant. 1992;7(11):1116\u201323.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"3249_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3899\/jrheum.110639","volume":"39","author":"J-M Kim","year":"2012","unstructured":"Kim J-M, Kwok S-K, Ju JH, Kim H-Y, Park S-H. Reactive hemophagocytic syndrome in adult korean patients with systemic lupus erythematosus: a case-control study and literature review. J Rheumatol. 2012;39(1):86\u201393.","journal-title":"J Rheumatol"},{"key":"3249_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12882-015-0217-z","volume":"17","author":"MN Bae","year":"2016","unstructured":"Bae MN, Kwak DH, Park SJ, Choi BS, Park CW, Choi YJ, Lee JW, Yang CW, Kim Y-S, Chung BH. Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis. BMC Nephrol. 2016;17:4.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03249-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:05:40Z","timestamp":1688375140000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03249-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03249-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"<b>Ethics approval and consent to participate<\/b>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patient and her parents were informed about the availability and importance of the data, including the clinical data, images, and health information, described in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"<b>Consent for publication<\/b>.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We have obtained informed consent in writing from the patient and her parents.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"<sup>1<\/sup>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China; <sup>2<\/sup>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; <sup>3<\/sup>Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China; <sup>4<\/sup>Department of Hematology, The Second Xiangya Hospital of Central South University, Changsha, China; <sup>5<\/sup>Clinical Research Center for Organ Transplantation in Hunan Province, Changsha, China; and <sup>6<\/sup>Clinical Immunology Center, Central South University, Changsha, China.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors details"}}],"article-number":"200"}}